The State of Louisiana has officially petitioned the U.S. Supreme Court to intervene and halt the distribution of the abortion pill mifepristone via mail, escalating a high-stakes legal battle over reproductive healthcare access. This request, filed this week, follows a recent ruling by a federal appeals court that temporarily restricted Food and Drug Administration (FDA)…
The United States Court of Appeals for the Fifth Circuit, based in New Orleans, issued a consequential ruling this week that threatens to restrict nationwide access to mifepristone, the primary drug used in medication abortions. The decision, which marks a significant escalation in the ongoing legal battles over reproductive healthcare, challenges the Food and Drug…
The United States Court of Appeals for the Fifth Circuit, based in New Orleans, has ignited a fierce national legal debate after issuing a series of rulings that challenge the long-standing regulatory framework governing mifepristone, a primary medication used in abortion care. This judicial intervention, occurring throughout 2023 and 2024, has drawn intense scrutiny from…
The United States Court of Appeals for the Fifth Circuit has ignited a fresh legal firestorm by issuing a restrictive ruling regarding the accessibility of mifepristone, a primary medication used for medical abortions. The decision, handed down this month in New Orleans, challenges long-standing FDA protocols that have allowed for the distribution of the drug…
The U.S. Supreme Court issued a temporary order on Friday, effectively preserving broad access to mifepristone, a commonly used abortion medication. The decision ensures that the drug remains available through mail-order pharmacies and via telehealth consultations, halting lower court restrictions that would have mandated in-person medical visits. This emergency intervention maintains the status quo while…
A federal appeals court in New Orleans has issued a ruling that significantly restricts access to mifepristone, a primary medication used for abortion in the United States, by prohibiting the distribution of the drug via mail. The decision, handed down by the U.S. Court of Appeals for the Fifth Circuit, mandates that the medication must…
